Navigation Links
Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Workshop
Date:11/4/2009

QUEBEC CITY, Nov. 4 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it received an invitation from the U.S. Department of Health and Human Services (HHS) to present at the Global Health Security Initiative Workshop (GHSI) on November 5, 2009 at 2:40 pm (EST) at the Fairfax at Embassy Row Hotel, Washington, D.C. During a session entitled Diagnostics and Vaccine Development Platforms, Medicago will discuss its ability to potentially improve the speed, capacity and cost of influenza vaccine production with its proprietary plant-based manufacturing platform and VLP technology.

The GHSI is an international, high-level forum for like-minded countries to discuss public health preparedness for chemical, biological, and radiological/nuclear (CBRN) threats as well as pandemic influenza. Amongst the GHSI policy priorities, the GHSI partners agreed on the need to build a global infrastructure for medical countermeasures (MCM). This year's workshop will provide an international opportunity for academia and industry partners to discuss research and development programs, products and new technologies as a first step towards coordinating preparedness efforts.

About Medicago

Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has potential to offer advantages of speed and cost over competitive technologies. It could deliver a vaccine for testing in about a month after the identification and reception of genetic sequences from a pandemic strain. This pr
'/>"/>

SOURCE Medicago Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
2. Medicago begins human clinical testing with its avian flu pandemic vaccine
3. Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine
4. Medicagos H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
5. Medicago succesfully expresses VLP antigen for A H1N1 strain
6. Medicago initiates work on Swine Flu strain
7. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
8. YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009
9. Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting
10. Additional Data From Fidaxomicins Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
11. ViroPharma to Present at Three November Healthcare Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , ,, BETHESDA, Md., Nov. 19 /PRNewswi...EX ), an innovator in biotechnology for diabetes t... consulting services to food, supplement, biotechn...y it closed the previously reported $6.3 million r...ors of 2,760,870 shares of its common stock and wa...
(Date:11/19/2009)... , MALVERN, Pa. and WALTHAM, Mass., Nov. 19... and Decision Resources find that the leading driv... in Europe is broad-spectrum activity against gram...variety of organisms that can cause nosocomial pne...hey look primarily for agents that provide appropr...
(Date:11/19/2009)... Top LASIK surgeons and recogn...d at Trusted LASIK Surgeons made brought their fel... in vision correction surgery, cataract surgery, a...ded American Academy of Ophthalmology (AAO) annual... Lindstrom, Dr. Shachar Tauber, Dr. David Huang, M...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNews...cine program on one product candidate at an unexpe...didate AD02 is planned to enter into,Phase II clin...pany,immediately follows the completion of two Pha... company based its fast decision on the first inte...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...y isotyping in only 5 minutes , Weiping Yang...lli ,Stratagene Cloning Systems, Inc. , Strata...g kit is a,simple, rapid and sensitive method fo... in a single step. Each IsoDetect test card is a s...ated anti-mouse antibodies for isotype determinati...
...o imitate neurodegeneration , , Rob D. Dic...ter J. McConathy a,b , a Department of Medicine...rsity of North Texas Health Science Center , ,...at uses Stratagenes,postmitotic human central ne...,aging human brain, neurodegeneration, and to inve...
...ess insertion and one-step purification from a mor...ion, One-Column Purification, and FLAG ,Epitope...borski John Bauer Peter,Vaillancourt ,Strata...IC cloning kit,with the new pCAL-n-FLAG vector. ...s designed for consistent, high-level production a...
Other Biology Technology:Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 2Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 3Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 4Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies 5Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 2Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 3Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 4Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 5Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 6Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 7High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 2High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 3High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 4High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 5High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 6High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 7High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 8
(Date:11/19/2009)..., Ind. - Purdue University scientists have helped ...ible for cell wall development in maize, an effort...oduce the biomass best suited for biofuels product...rpita, a professor of plant cell biology, publishe... journal Plant Physiology on Thursday (Nov. 19)....
(Date:11/19/2009)..., University of Cincinnati professor of paleontolo... co-author Michael Foote of the University of Chic... Science with their paper, "Epicontinental Seas ...xtinction and Origination." , For many years, pa...y of biodiversity have focused on charting the man...
(Date:11/19/2009)...frey Receives Competitive NIH Director,s T-R01 Awa...in the Dark , Dr. Samie Jaffrey, associate profe...ege, is among the first researchers to win a prest...m the National Institutes of Health. Dr. Jaffrey a...n recognition technologies that may some day speed...
Breaking Biology News(10 mins):Maize cell wall genes identified, giving boost to biofuel research 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Professor Uses H1N1 as a Teaching Tool 56956 1Professor Uses H1N1 as a Teaching Tool 56956 2Professor Uses H1N1 as a Teaching Tool 56956 3Muslim Coalition to Host D C Hearing on Health Care Reform 56951 1Muslim Coalition to Host D C Hearing on Health Care Reform 56951 2synthesis Whats the Real Objective Outcomes 21 56946 1
...a newly established nonprofit organization, is ple...website (www.rsrt.org). In the wake of last year,... the Trust has been formed to pursue the next step... the increasing range of MECP2 spectrum disorders....s addressing the underlying MECP2 pathology to cli...
...http://www.kount.com ), a leading provider of frau... that the company has received a US patent for,its...ls say patent number 7,330,871 "Online Machine Dat...ethod for identifying a,customer computer involved... "An important step in combating fraud is accurat...
...rgy and environment experts are participating in a...ouston, addressing the implications of climate cha...The Science and Policy of Climate Change" lecture ...from 5:45 to 7:15 p.m. Mondays through Nov. 17. T...oom 101 of the Cameron Building on the UH campus. ...
Other Biology News:The Rett Syndrome Research Trust launches operations 2The Rett Syndrome Research Trust launches operations 3Kount Receives Patent for Device Fingerprinting 2Experts discuss climate change during UH lecture series 2
Freund's Incomplete Adjuvant, Modified from Calbiochem
...es output at 470 nm; includes interface cable to S...to rack or desktop boxes The LS-450 Blue LED Pul...lsed or continuous output at 470 nm -- the blue re...is designed for use with Ocean Optics spectrometer...
...NA microarray slides for microRNA expression prof...porate Exiqons unique Locked Nucleic Acid (LNA) te...ellent mismatch discrimination for short microRNA ...han 1 g total RNA (no need for microRNA enrichment...
Freund's Complete Adjuvant, Modified, Mycobacterium butyricum from Calbiochem
Biology Products: